Satsuma Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Satsuma Pharmaceuticals

28/03/2023 22:04

* Satsuma Pharmaceuticals Inc  STSA.OQ  reported a quarterly
adjusted loss of 70 cents​​ per share for the quarter ended in
December. The mean expectation of five analysts for the quarter
was for a loss of 36 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Satsuma Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 70 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Satsuma Pharmaceuticals Inc shares had fallen by 5.5% this
quarter.
    * The company reported a quarterly loss of $23.13 million.
    * Wall Street's median 12-month price target for Satsuma
Pharmaceuticals Inc is $2.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 28 at 09:04 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.36          -0.70          Missed
 Sep. 30 2022      -0.54          -0.48          Beat
 Jun. 30 2022      -0.49          -0.52          Missed
 Mar. 31 2022      -0.49          -0.49          Met